FDA Warning: Hidden Dangers of Smuggled Tirzepatide boomrx #peptides #fda #compoundingpharmacy #clinicalmedicine #patientaccess BoomRX BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved FDA Peptide Category 2 Removal & Public Meeting July 23rd Mansi Hukmani posted on the topic LinkedIn